Block Listing Interim Review and TVR Update

RNS Number : 0490S

CVS Group plc

12 July 2022

 

12 July 2022

CVS Group plc

("CVS" or the "Company")

Block Listing Interim Review and TVR Update

CVS, one of the UK's leading providers of integrated veterinary services, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements.  References to securities are to the Company's ordinary shares of 0.2 pence each ("Ordinary Shares").

Name of the company:		CVS Group plc
Name of relevant scheme:		1.  CVS Group plc 2017-2020 Sharesave Scheme; 2.  CVS Group plc 2018-2021 SAYE Sharesave Scheme; and 3.  CVS Group 2018 SAYE Plan
Period of return:	From:	1.  12 January 2022 2.  12 January 2022 3.  12 January 2022	To:	11 July 2022
Balance of unallotted securities under scheme(s) from previous return:		1.  787 2.  198,472 3.  350,000
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		1.  Nil 2.  Nil 3.  Nil
Less:  Number of securities issued / allotted under scheme(s) during period:		1.  557 2.  178,874 3.  1,710
Equals: Balance under scheme(s) not yet issued / allotted at end of period:		1.  230 2.  19,598 3.  348,290
Number and class of securities originally listed and the date of admission:		1.  114,302 Ordinary Shares admitted on 11 January 2021 and 1,535   Ordinary Shares admitted on 1 September 2021 2.  296,069 Ordinary Shares admitted on 1 September 2021 3.  350,000 Ordinary Shares admitted on 30 December 2021 761,906 Total

Total Voting Rights

The number of securities that have been issued during the block listing review period stated above includes 26,201 new Ordinary Shares issued during July 2022 in connection with the exercise of employee share options awarded in November 2018 and maturing on 1 January 2022 under the CVS Group plc 2018-2021 SAYE Sharesave Scheme .

Following the issue of these new Ordinary Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, the Company has a total issued share capital of 71,146,238 Ordinary Shares, each carrying one voting right.  The Company holds no Ordinary Shares in treasury so the total number of voting rights is therefore 71,146,238.

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts: CVS Group plc Jenny Farrer Company Secretary	Tel: [phone]
Singer Capital Markets (Nominated Adviser & Broker) Aubrey Powell/ Jen Boorer/ Rachel Hayes	Tel: [phone]

 

END

 

 

MSCBDGDRXUBDGDB